erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

poor air quality is not unique to the uk or europe. more than 90% of people around the world breathe dangerous levels of air pollution, according to the.